Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Preferred Shares Issued (2022 - 2023)

Historic Preferred Shares Issued for Cullinan Therapeutics (CGEM) over the last 2 years, with Q1 2023 value amounting to $1.8 million.

  • Cullinan Therapeutics' Preferred Shares Issued rose 12812.5% to $1.8 million in Q1 2023 from the same period last year, while for Dec 2023 it was $1.8 million, marking a year-over-year decrease of 2315.79%. This contributed to the annual value of $1.8 million for FY2023, which is 2315.79% down from last year.
  • Per Cullinan Therapeutics' latest filing, its Preferred Shares Issued stood at $1.8 million for Q1 2023, which was up 12812.5% from $175000.0 recorded in Q4 2022.
  • Cullinan Therapeutics' 5-year Preferred Shares Issued high stood at $1.8 million for Q1 2023, and its period low was $175000.0 during Q4 2022.